🇬🇧 SUGEMALIMAB in United Kingdom

SUGEMALIMAB (SUGEMALIMAB) regulatory status in United Kingdom.

Marketing authorisation

MHRA

  • Local brand name: Cejemly
  • Status: approved

SUGEMALIMAB in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in United Kingdom

Frequently asked questions

Is SUGEMALIMAB approved in United Kingdom?

Yes. MHRA has authorised it.

Who is the marketing authorisation holder for SUGEMALIMAB in United Kingdom?

Marketing authorisation holder not available in our data.